Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mason

Showing results (421-430 of 977) with videos related to

Pageof 98
Sort By:
Virology|September 1, 1991
Characterization of the core promoter and enhancer of duck hepatitis B virusC Liu, L D Condreay, J B Burch, et al.
Placenta|January 16, 2007
Expression of cathepsin P mRNA, protein and activity in the rat choriocarcinoma cell line, Rcho-1, during giant cell transformationM Hassanein, B D Korant, G Lu, et al.
The American Journal of Cardiology|June 1, 1979
Canine electrophysiology of encainide, a new antiarrhythmic drugM Sami, J W Mason, G Oh, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|March 31, 2021
The UK foot and ankle COVID-19 national (FAlCoN) audit - Regional variations in COVID-19 infection and national foot and ankle surgical activityLyndon W Mason, Karan Malhotra, Linzy Houchen-Wollof, et al.
Nucleic Acids Research|October 1, 1996
The amino-terminal domain of the transcription termination factor TTF-I causes protein oligomerization and inhibition of DNA bindingE E Sander, S W Mason, C Munz, et al.
Vaccine|October 26, 2002
Enhanced surveillance of primary measles mumps and rubella (MMR) immunisation in WalesBrendan W Mason, Daniel R h Thomas, Roland L Salmon
Biological Psychiatry|July 1, 1993
Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disordersR Yehuda, D Boisoneau, J W Mason, et al.
Annals of Internal Medicine|October 1, 1970
Plasma kallikrein and Hageman factor in Gram-negative bacteremiaJ W Mason, U Kleeberg, P Dolan, et al.
Cancer Management and Research|April 18, 2014
A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongationJay W Mason, Thomas E Moon, Erin O'Boyle, et al.
Foot (Edinburgh, Scotland)|February 23, 2020
Posterior malleolar fractures: A CT guided incision analysisSurya Gandham, Graham Millward, Andrew P Molloy, et al.
Pageof 98

Showing results (421-430 of 977) with videos related to

Sort By:
Pageof 98
Virology|September 1, 1991
Characterization of the core promoter and enhancer of duck hepatitis B virusC Liu, L D Condreay, J B Burch, et al.
Placenta|January 16, 2007
Expression of cathepsin P mRNA, protein and activity in the rat choriocarcinoma cell line, Rcho-1, during giant cell transformationM Hassanein, B D Korant, G Lu, et al.
The American Journal of Cardiology|June 1, 1979
Canine electrophysiology of encainide, a new antiarrhythmic drugM Sami, J W Mason, G Oh, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|March 31, 2021
The UK foot and ankle COVID-19 national (FAlCoN) audit - Regional variations in COVID-19 infection and national foot and ankle surgical activityLyndon W Mason, Karan Malhotra, Linzy Houchen-Wollof, et al.
Nucleic Acids Research|October 1, 1996
The amino-terminal domain of the transcription termination factor TTF-I causes protein oligomerization and inhibition of DNA bindingE E Sander, S W Mason, C Munz, et al.
Vaccine|October 26, 2002
Enhanced surveillance of primary measles mumps and rubella (MMR) immunisation in WalesBrendan W Mason, Daniel R h Thomas, Roland L Salmon
Biological Psychiatry|July 1, 1993
Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disordersR Yehuda, D Boisoneau, J W Mason, et al.
Annals of Internal Medicine|October 1, 1970
Plasma kallikrein and Hageman factor in Gram-negative bacteremiaJ W Mason, U Kleeberg, P Dolan, et al.
Cancer Management and Research|April 18, 2014
A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongationJay W Mason, Thomas E Moon, Erin O'Boyle, et al.
Foot (Edinburgh, Scotland)|February 23, 2020
Posterior malleolar fractures: A CT guided incision analysisSurya Gandham, Graham Millward, Andrew P Molloy, et al.
Pageof 98